News | April 23, 2025
WHO prequalifies Syngenta’s innovative insecticide Sovrenta
A new weapon in the global fight against malaria
A new weapon in the global fight against malaria
VaxiFlu-4 is being marketed by Zydus Vaxxicare-a division of the group focussing on preventives
International Meeting of World Pharmacopoeias serves as a vital platform to foster international collaboration in pharmacopoeial science and regulatory harmonization
The overall clinical efficacy of Zaynich across indications was 98% at the test-of-cure
The certification marks a new chapter in Windlas Biotech’s growth trajectory,
ICMR will continue to track trends in HMPV circulation throughout the year
2.92 acre facility will combine tradition and innovation, offering new opportunities for holistic healing, specialized clinics, and skill development to be constructed at a cost of around Rs. 185 crore
Inaugurates new facilities to further NIMHANS’ mission of delivering cutting-edge care in mental health and neurosciences
The MoU signed in 2022 has progressed and culminated in the subsumption of FOGSI-led Manyata initiative’s 20 quality standards across NABH’s Certification programs
India has been declared ‘functional’ against all the core regulatory functions of the WHO Global Benchmarking Tool Version VI
Subscribe To Our Newsletter & Stay Updated
